What Is a PSA Test and Should You Be Getting One? A Plain-English Guide

If you’re a man over 50, your doctor has probably mentioned the PSA test — or maybe recommended you start thinking about it. And if you’ve looked into it, you’ve likely found confusing, sometimes contradictory information about whether it’s worth doing, what the results mean, and what happens if it comes back elevated.

This plain-English guide explains what a PSA test is, what different levels actually mean, the real benefits and limitations of the test, and how to have an informed conversation with your doctor about it.

What Is the PSA Test?

PSA stands for Prostate-Specific Antigen — a protein produced by cells in the prostate gland (both normal and cancerous cells). A PSA test is a simple blood test that measures the concentration of this protein in the bloodstream.

PSA is not a cancer marker per se — it’s a prostate marker. Anything that irritates or enlarges the prostate can raise PSA: benign prostatic hyperplasia (BPH), prostatitis (prostate inflammation), a prostate infection, recent sexual activity, a prostate biopsy, or a digital rectal exam. Prostate cancer is one cause — and an important one — but not the only cause.

What Do PSA Numbers Mean?

Traditional interpretation used a threshold of 4.0 ng/mL as the cutoff for concern. Current thinking is more nuanced:

• Below 1.0 ng/mL: Low risk, associated with less than 1% likelihood of prostate cancer over the next decade
• 1.0–2.5 ng/mL: Low to normal range; annual monitoring typically recommended
• 2.5–4.0 ng/mL: Intermediate range; more careful monitoring and discussion with your doctor warranted
• 4.0–10.0 ng/mL: Elevated; prostate cancer found in about 25% of men in this range on biopsy
• Above 10.0 ng/mL: Significantly elevated; roughly 50% chance of prostate cancer on biopsy

Age-adjusted norms are increasingly used, since PSA naturally rises with age as the prostate grows:

• Age 40–49: below 2.5 ng/mL considered normal
• Age 50–59: below 3.5 ng/mL
• Age 60–69: below 4.5 ng/mL
• Age 70+: below 6.5 ng/mL

PSA Velocity and PSA Density: Why Trends Matter More Than Single Numbers

A single PSA reading provides limited information. Two measurements over time tell a much more useful story:

• PSA velocity: The rate of change over time. A rise of more than 0.75 ng/mL per year is concerning even if the absolute number is in the “normal” range. A rapid rise over 12–18 months warrants further evaluation regardless of absolute level.
• PSA density: PSA level divided by prostate volume (measured by ultrasound). A large prostate naturally produces more PSA. High density relative to prostate size is more concerning than the same number from a small prostate.

The Benefits and Limitations of PSA Testing

Benefits

• Can detect prostate cancer before symptoms develop, enabling earlier treatment when outcomes are better
• Establishes a baseline for monitoring changes over time
• Can detect non-cancerous prostate problems (BPH, prostatitis) that benefit from treatment
• Inexpensive and non-invasive

Limitations

• High false positive rate: most elevated PSA readings are not cancer
• Can lead to unnecessary biopsies, which carry small but real risks
• Detects some cancers that would never have caused harm (“overdiagnosis”) — prostate cancer often grows very slowly
• Misses some cancers in men with large prostates that dilute the PSA reading

Who Should Get a PSA Test and When?

Current guidelines vary by organization, which contributes to the confusion:

• American Cancer Society: Recommends discussing PSA testing at age 50 for average-risk men; age 45 for men with first-degree relatives diagnosed with prostate cancer before 65; age 40 for men with multiple first-degree relatives with early prostate cancer
• US Preventive Services Task Force (USPSTF): Recommends discussion about screening for men aged 55–69
• African American men have 60% higher incidence rates and should start discussions earlier (age 40–45)

The key word across guidelines is “discussion” — PSA screening is not a simple “yes do it” or “no don’t.” It’s a decision made with your doctor based on individual risk factors, values, and preferences.

What Happens If PSA Is Elevated?

An elevated PSA typically leads to:

1. Repeat testing after a period of abstaining from activities that could transiently raise PSA (sex, exercise, bike riding)
2. Additional tests to refine risk: free-to-total PSA ratio (lower ratio is more concerning), PHI (Prostate Health Index), 4Kscore, or MRI of the prostate
3. MRI-guided biopsy if risk assessment indicates it — modern MRI-targeted biopsies are far more accurate than the older systematic biopsy approach

An elevated PSA is not a diagnosis. It’s a signal to investigate further. Many men who undergo biopsy after elevated PSA do not have cancer.

PSA and Prostate Supplements

Some prostate supplements affect PSA readings. Notably, saw palmetto does not appear to affect PSA levels. However, finasteride and dutasteride (pharmaceutical 5-alpha reductase inhibitors) reduce PSA by approximately 50% — meaning men on these medications need PSA thresholds adjusted accordingly. If you’re taking any prostate supplement or medication, disclose it to your doctor before PSA testing. Our piece on early signs of prostate problems provides useful context on what to watch for beyond PSA.

Frequently Asked Questions

Does a PSA test detect prostate cancer?

It detects elevated PSA, which can be caused by prostate cancer among other things. A high PSA requires follow-up testing — it is not itself a cancer diagnosis.

Can I lower my PSA naturally?

Addressing underlying causes of elevation can lower PSA: treating prostatitis with antibiotics reduces PSA significantly. Dietary changes (lycopene, anti-inflammatory diet) may modestly reduce PSA over time. Losing weight reduces PSA in obese men. These effects are modest — dramatically falling PSA from “natural” interventions is generally not realistic without addressing a specific underlying cause.

Is a prostate biopsy always required after an elevated PSA?

No — this is where modern advances have been significant. MRI of the prostate can now identify suspicious areas that warrant targeted biopsy while avoiding biopsy of areas that appear benign. Many men with moderately elevated PSA can now be monitored or have MRI-guided evaluation rather than systematic biopsy.

The Bottom Line

The PSA test is an imperfect but useful tool. Its value lies not in a single reading but in context: your age, your risk factors, the trend over time, and the additional tests used to refine its findings. Understanding these nuances allows you to have a more informed conversation with your doctor rather than either dismissing the test or being unnecessarily alarmed by a modestly elevated number.